- Report
- August 2025
- 205 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- February 2025
- 246 Pages
United States
From €4203EUR$4,799USD£3,648GBP
- Report
- October 2025
- 150 Pages
Europe, Asia Pacific, ... Europe, Asia Pacific, North America
From €5211EUR$5,950USD£4,523GBP
- Report
- September 2025
- 150 Pages
Middle East
From €4335EUR$4,950USD£3,763GBP
- Report
- August 2025
- 100 Pages
Middle East
From €4335EUR$4,950USD£3,763GBP
- Report
- July 2025
- 120 Pages
United States
From €5211EUR$5,950USD£4,523GBP
- Report
- August 2025
- 130 Pages
Africa, Middle East
From €3503EUR$4,000USD£3,041GBP
- Report
- October 2025
- 96 Pages
Middle East
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 100 Pages
Europe
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 90 Pages
North America
From €3022EUR$3,450USD£2,623GBP
- Report
- August 2025
- 80 Pages
Middle East, Africa
From €3022EUR$3,450USD£2,623GBP
- Report
- August 2025
- 98 Pages
Asia Pacific
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 101 Pages
Europe
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2025
- 95 Pages
Asia Pacific
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2025
- 98 Pages
Europe
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2023
- 56 Pages
Global
€2146EUR$2,450USD£1,862GBP
- Report
- February 2023
- 336 Pages
Global
From €4203EUR$4,799USD£3,648GBP
- Report
- June 2024
- 569 Pages
Global
From €1312EUR$1,550USD£1,100GBP
- Report
- December 2022
- 437 Pages
Global
From €4710EUR$5,566USD£3,950GBP
- Report
- September 2020
- 240 Pages
Global
From €4291EUR$4,899USD£3,724GBP

Biomanufacturing is a sub-sector of biotechnology that focuses on the production of biopharmaceuticals, medical devices, and other products derived from living organisms. It involves the use of biotechnology processes such as genetic engineering, cell culture, and fermentation to produce these products. The biomanufacturing market is driven by the increasing demand for biopharmaceuticals, medical devices, and other products derived from living organisms. This demand is driven by the growing prevalence of chronic diseases, the increasing aging population, and the need for more effective treatments.
The biomanufacturing market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies in the market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more